Clinical Trial Update: Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating specific Lp(a) apheresis for regression of coronary and carotid atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Disease
• Coronary Artery Disease

Snippet

Sponsor: Russian Cardiology Research and Production Center | Conditions: Atherosclerosis, Coronary Disease | Phase 3 | Status: COMPLETED